Related Experiment Video
Updated: Mar 20, 2026
07:27
Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome
Published on: January 23, 2026
401
Robotic Lung Resection for Non-Small Cell Lung Cancer
Benjamin Wei1, Shady M Eldaif2, Robert J Cerfolio3
1Division of Cardiothoracic Surgery, University of Alabama-Birmingham Medical Center, Birmingham, AL, USA.
Surgical Oncology Clinics of North America
|June 5, 2016
Summary
Robotic-assisted pulmonary lobectomy is a viable option for patients who can tolerate traditional surgery. This minimally invasive approach shows reduced complications and shorter recovery times compared to open thoracotomy.
Area of Science:
- Thoracic Surgery
- Minimally Invasive Procedures
- Robotic Surgery
Background:
- Pulmonary lobectomy is a standard surgical procedure for lung diseases.
- Conventional thoracotomy carries significant risks and prolonged recovery.
- Robotic-assisted surgery offers potential advantages in precision and patient outcomes.
Purpose of the Study:
- To evaluate the safety and efficacy of robotic-assisted pulmonary lobectomy.
- To compare robotic lobectomy outcomes with traditional thoracotomy.
- To assess the benefits of robotic surgery in thoracic procedures.
Main Methods:
- Review of patients undergoing robotic-assisted pulmonary lobectomy.
- Comparison of perioperative outcomes between robotic and thoracotomy approaches.
- Analysis of complication rates, including blood loss, air leak, and length of stay.
Main Results:
- Robotic lobectomy demonstrated decreased blood loss, transfusion rates, and air leaks.
- Shorter chest tube duration, hospital stay, and lower mortality were observed with robotic assistance.
- Robotic surgery provided enhanced optics, dexterity, and surgeon ergonomics compared to video-assisted thoracic surgery.
Conclusions:
- Robotic-assisted pulmonary lobectomy is a safe and effective alternative to thoracotomy for select patients.
- The procedure offers significant advantages in reducing perioperative morbidity and improving surgical ergonomics.
- Further research is needed on long-term oncologic outcomes and cost-effectiveness.
